(Reuters) - The medical diagnostic testing firm also posted a flat
quarterly profit, weighed by costs linked to the offer from
Switzerland-based Roche. Acquisition activity has heated up in
the sector as bigger firms eye smaller niche diagnostics
companies with promising technologies.
Second-quarter profit was $7 million or 20 cents per share,
compared with $7.2 million, or 20 cents per share, a year
earlier.
Read more at Reuters.com Mergers News
quarterly profit, weighed by costs linked to the offer from
Switzerland-based Roche. Acquisition activity has heated up in
the sector as bigger firms eye smaller niche diagnostics
companies with promising technologies.
Second-quarter profit was $7 million or 20 cents per share,
compared with $7.2 million, or 20 cents per share, a year
earlier.
Read more at Reuters.com Mergers News
No comments:
Post a Comment